Jon Cohen AIDS Research Collection

Browse Collection: Multiple Items

The Immune Response Corporation

Access restricted by copyright holder.
Author
Robertson, Stephens & Company
Publication
Robertson, Stephens & Company
1991-08-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation

Access restricted by copyright holder.
Author
Robertson, Stephens & Company
Publication
Robertson, Stephens & Company
1992-10-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

1990 Third Quarter Report to Stockholders

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1990
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Reports Third Quarter 1990 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-11-06
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: Common Stock

Access restricted by copyright holder.
Author
Dillon, Read & Company.
Publication
Dillon, Read & Company.
1990-04-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation and Rhone-Poulenc Rorer Inc. Increase Funding for HIV Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-12-20
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Form S-1: Registration Statement under the Securities Act of 1933

Author
Immune Response Corporation
Publication
1989-09-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Files Proposed Initial Public Offering of 2,200,000 shares of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-04-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Makes Initial Public Offering of 2,200,000 Shares of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-05-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports First Quarter 1990 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-06-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Reports Second Quarter 1990 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-08-08
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports Start of Clinical Trial on HIV Immunotherapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-09-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports Third Quarter 1990 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-11-06
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

AIDS [Organization chart]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1990-04-20
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
charts (graphic document.

1990 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Immune Response Corp. (OTC - IMNR): A Technical Review of the Rheumatoid Arthritis Program

Access restricted by copyright holder.
Author
Kidder, Peabody & Co.
Publication
Kidder, Peabody & Co.
1990-11-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: Common Stock

Access restricted by copyright holder.
Author
Montgomery Securities | Robertson, Stephens & Company
Publication
Montgomery Securities | Robertson, Stephens & Company
1991-04-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Annual Report to Stockholders

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1994-04-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Fourth Quarter and Year-End 1990 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-03-01
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Annual Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

Author
Immune Response Corporation
Publication
1990-12-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation Reports First Quarter 1991 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-05-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Presents Trial Results on HIV Therapeutic Vaccine

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-05-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Research: The Immune Response Corporation*# - IMNR (OTC)

Access restricted by copyright holder.
Author
Smith Barney Inc.
Publication
Smith Barney Inc.
1991-03-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

1991 First Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Independent Study Supports Immune Response’s Therapeutic Vaccine Strategy against HIV

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-06-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Annual Report to Stockholders

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1991-04-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: Common Stock

Access restricted by copyright holder.
Author
Montgomery Securities | Robertson, Stephens & Company
Publication
Montgomery Securities | Robertson, Stephens & Company
1991-04-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Second Quarter 1991 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-07-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Makes Public Offering of 1,300,000 Shares of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-10-29
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Consolidated Condensed Statements of Operations

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation Files Investigational New Drug Application for Second Rheumatoid Arthritis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-01-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

1992 Third Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Results of HIV Immunotherapeutic Phase I/II Clinical Trial Demonstrate Effect on Viral Burden in HIV-Infected Individuals

Access restricted by copyright holder.
Author
Immune Response Corporation | Rhône-Poulenc Rorer Pharmaceuticals
Publication
Immune Response Corporation | Rhone-Poulenc Rorer Pharmaceuticals
1993-06-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

IPL, Immunization Products Limited: A Joint Venture of Rhone-Poulenc Rorer Inc. and the Immune Response Corporation [Press kit]

Access restricted by copyright holder.
Author
Immune Response Corporation | Rhône-Poulenc Rorer Pharmaceuticals
Publication
1993
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press kits

The Immune Response Corporation 1990 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corpation
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: 1993 Second Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Change of 1934.

Author
Immune Response Corporation
Publication
1993-06-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

New Maalox(R) Products from Rhone-Poulenc Rorer Demonstrate Growth Beyond Antacids

Access restricted by copyright holder.
Author
Rhône-Poulenc Rorer Pharmaceuticals
Publication
Rhone-Poulenc Rorer Pharmaceuticals
1993-07-27
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

RPR Forms Arcola Laboratories -- New Generic Drug Division to Market Generic Versions of RPR Products

Access restricted by copyright holder.
Author
Rhône-Poulenc Rorer Pharmaceuticals
Publication
Rhone-Poulenc Rorer Pharmaceuticals
1993-07-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Rhone-Poulenc Rorer Reports Good Second Quarter Earnings Growth

Access restricted by copyright holder.
Author
Rhône-Poulenc Rorer Pharmaceuticals
Publication
Rhone-Poulenc Rorer Pharmaceuticals
1993-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Files Two Investigational New Drug Applications for Autoimmune Disease Treatments

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-11-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Granted Australian Patent on Autoimmune Disease Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-05-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces a $5 Million Milestone Payment from Agouron Pharmaceuticals, Inc.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1999-02-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives U.S. Patennt for the Treatment of T Cell Cancers

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1999-02-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1998 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1999-01-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces a $5 Million Payment from Agouron

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1999-01-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

1996 First Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Reports First Quarter 1992 Financial Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-04-29
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation and Rhone-Poulence Rorer Inc. Commit $18 Million Additional Funding for AIDS Joint Venture

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-05-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1991 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-02-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

1992 First Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Fourth Quarter and Year-End 1991 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-02-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1992 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-07-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Dose-Ranging Study Shows HIV Immunotherapeutic Stimulates Antibody and Cellular Responses

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Appoints Vice Presidents of Research and Regulatory Affairs

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-06-01
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Begins Clinical Trial of New Rheumatoid Arthritis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-09-08
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

1992 Second Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Proposed Acquisition of TargeTech, Inc.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-10-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Completes Acquisition of TargeTech, Inc.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-11-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation (IMNR $16-3/4)

Access restricted by copyright holder.
Author
Robertson, Stephens & Company
Publication
Robertson, Stephens & Company
1991-08-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation’s Wholly Owned Subsidary, TargeTech, Inc., Receives U.S. Patent on Gene Therapy Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-12-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Author
Immune Response Corporation
Publication
1992-11-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Fourth Quarter and Year-End 1992 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-02-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1992 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-10-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Appoints Vice President of Administration

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-10-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Appoints Vice President of Administration

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-10-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1992 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-10-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

IPL, Immunizaiton Products Limited: A Joint Venture of Rhone-Poulenc Rorer Inc. and the Immune Response Corporation [Press kit]

Access restricted by copyright holder.
Author
Rhône-Poulenc Rorer Pharmaceuticals | Immune Response Corporation
Publication
1993
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press kits

The Immune Response Corporation and the National Institutes of Health Begin First Pediatric Clinical Trial of Remune(TM) HIV Therapy

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-05-29
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press kits

The Immune Response Corporation’s Licensed Gene Delivery Technology Receives United States Patent

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-05-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Announces Second Quarter 1996 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Data Safety Monitoring Board Meeting on Remune(TM) Phase III Clinical Trials

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-12-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Presents Remune(TM) Data at the Second Annual Institute of Human Virology Meeting

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-09-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives Final Payment of $12 Million from Private Placement

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-09-27
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives Final Payment of $12 Million form Private Placement

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-09-29
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1997 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-07-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Presents Remune(TM) Data at the Second Annual Institute of Human Virology Meeting

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-09-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation’s Licensed Cancer Vaccine Technology Receives United States Patent

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-10-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Presents Exploratory Phase II Clinical Trial Data on Psoriasis

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-09-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Trauger Interview

Author
Cohen, Jon, 1958-
Publication
1991-01-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
transcripts
Back to Top Go to Pagination

The Immune Response Corporation Completes Enrollment for Phase II/III HIV Therapeutic Vaccine Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
The Immune Response Corporation
1991-09-10
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Comments on Interest in Progress on HIV Therapeutic Vaccine

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
The Immune Response Corporation
1991-11-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1991 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
The Immune Response Corporation
1991-11-06
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation PCR Assay Correlates Viral Burden with Clinical Stage of HIV Infection

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
The Immune Response Corporation
1992-03-05
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Annual Report, The Immune Response Corporation, for Fiscal Year Ending December 31, 1991]

Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-12-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

[Invitation to the Annual Meeting of Stockholders, Immune Response Corporation]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1992-04-06
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
invitations

1991 Annual Report to Stockholders

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-02-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Publication of Results from Thailand Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-08-25
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Initiation of Open-Label Clinical Trial of Rheumatoid Arthritis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-08-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1998 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-07-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Announces Data Safety Monitoring Board Meeting on Remune Phase II Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-06-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Publication of Clinical Data Concerning Immune Responses in Individuals Treated with Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-06-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Begins Additional Combination Drug Trial with Remune in the United States

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-06-17
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Encouraging Preliminary Clinical Results Reported for Immune-Based Therapy Remune

Author
New York University. Medical Center
Publication
New York University. Medical Center
1998-07-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation and Schering-Plough in Agreement to Develop Hepatitis Gene Therapy Products

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-07-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation and Agouron Pharmaceuticals, Inc. Announce Collaboration to Commercialize Remune.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-06-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces First Quarter 1998 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-05-05
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Completion of $10 Million Private Placement

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-04-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Publication of Preclinical Data on Potential Preventative HIV Vaccine

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-04-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation, 1997 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

Long-Term Follow-Up Data Published on Initial Patients Treated With Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation’s Licensed Technology Shown to Eradicate Brain Tumor Cells in Laboratory Animals

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Addition of Dr. Melvin Perelman to Its Board of Directors

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces First Quarter 1996 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Favorable Results from the Thailand Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-02-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Shows Treatment with Remune Has a Favorable Impact on HIV Marker of Disease Progression

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-02-10
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1997 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Initiation of Remune Clinical Trial in Switzerland

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-27
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Remune Activity Against Different Strains of HIV-1

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces the Appointment of Charles J. Cashion as Senior Vice President

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Announces the Appointment of Steven P. Richieri as Chief Operating Officer

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports New Data Supporting the Importance of Maintaining HIV-Specific Immune Function

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1998-01-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Clinical Trials Begin in Thailand of HIV Treatment Proposed by Dr. Jonas Salk

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: Second Quarter 1995

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Completes Enrollment of Phase II Clinical Trial Using Psoriasis Treatement

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation’s Licensed Technology Receives U.S. Patent

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

First Patients Treated in Nationwide Clinical Trial of HIV Therapy Proposed by Dr. Jonas Salk

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Completes Enrollment of Phase II Clinical Trial Using Rheumatoid Arthritis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives Clearance from Food and Drug Administration to Begin Phase III HIV Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-02-27
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1997 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-10-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Presents Results from Phase II Clinical Trial for Rheumatoid Arthritis at American College of Rheumatology Annual Meeting

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-11-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Data Safety Monitoring Board Meeting on Remune Phase III Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-12-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Treats First Patient in Phase IIb Clinical Trial Using Rheumatoid Arthritis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-12-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Treats First Patient in Phase II Clinical Trial Using Psoriasis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-11-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1995 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-02-08
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Corrects Dow Jones News Reports

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-02-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Food and Drug Administration Allows Release of HIV-1 Immunogen from Commercial-Scale Manufacturing Facility

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-02-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Immune Response Corp. (Nasdaq): IMNR [Company profile for prospective investors]

Access restricted by copyright holder.
Author
Gibson Nostas Financial Communications
Publication
Gibson Nostas Financial Communications
1996-02-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Expanded Access Program of Remune to Treat HIV Infection

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives United States Patent Office Notice of Allowance for Licensed Cancer Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-01
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Announces Clinical Trial in Spain Using Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Combination Drug Trial Using Remune in Collaboration with Glaxo and Merck

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-11-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: 1996 Second Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Signs Agreement with Viru-Tech Limited for Remune in South America and Central America

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-08
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Insiders Complete $15.8 Million Private Placement in the Immune Response Corporation

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-04-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives United States Patent on Autoimmune Disease Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-03-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports New Antiviral Activity Using Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-04-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Completes Enrollment of 2,500 Patient Phase III Clinical Trial of Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-05-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces First Quarter 1997 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-04-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Note to Reporters and Editors: AIDS Malignancy Conference Convenes at NIH

Author
National Cancer Institute (U.S.)
Publication
National Cancer Institute (U.S.)
1997-04-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

Results of HIV Immunotherapeutic Phase II/III Clinical Trial Demonstrate Effect on Viral Burden in HIV-Infected Individuals

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-06-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Immune Response and Rhone-Poulenc Rorer Expand HIV/AIDS Joint Venture to Include International Territories

Access restricted by copyright holder.
Author
Rhône-Poulenc Rorer Pharmaceuticals
Publication
Rhone-Poulenc Rorer Pharmaceuticals
1993-04-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Reports First Quarter 1993 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-04-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives U.S. Patent on HIV Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-10-27
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1993 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-07-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Files Registration Statement with SEC

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-07-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Granted European Patent on Autoimmune Disease Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-01-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Files Registration Statement with S.E.C.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-07-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1993 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-07-22
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: Common Stock Prospectus

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1990-05-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation: Common Stock Prospectus

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
promotional materials

The Immune Response Corporation: 1994 Second Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: 1991 Third Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: 1991 Second Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Fourth Quarter and Year-End 1994 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-03-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Investment Highlights

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-03-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Regains All Rights to HIV Immunotherapeutic from Rhone-Poulenc Rorer, Inc.

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-03-03
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces First Quarter 1995 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-04-20
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Begins Rheumatoid Arthritis Phase II Clinical Trials

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-08-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Begins Psoriasis Phase II Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-09-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Granted Japanese Patent on HIV Therapy

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-09-05
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1995 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-10-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces the Appointment of New Chief Scientific Officer

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-10-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces the Appointment of New Senior Vice President, Operations

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-10-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 10-Q, Quarterly Report for Immune Response Corporation, September 30, 1995]

Author
Immune Response Corporation
Publication
1995-11-06
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Granted European Notice of Allowance and Russian Patent on HIV Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-12-13
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1994 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-03-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1994 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-07-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Relocates TargeTech Gene Therapeutics Operations to California Headquarters

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Granted Exclusive License for Potential Tumor Vaccine Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-07-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Announces Addition of Vice President of Corporate Development

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-11-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1994 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-10-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Discovers T Cells Involved in Psoriasis

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-09-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Publication of Results from Phase II Dose-Ranging Clinical Trial of HIV Immunotherapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-10-03
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Dennis J. Carlo Ph.D. Elected President and Chief Executive Officer at the Immune Response Corporation

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-09-20
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 10-Q, Quarterly Report, September 30, 1994, the Immune Response Corporation]

Author
Immune Response Corporation
Publication
1994-11-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

FDA Advisory Committee Recommends Phase III Clinical Trial of HIV Immunotherapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-01-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form Q-10, Quarterly Report, June 30, 1994, the Immune Response Corporation]

Author
Immune Response Corporation
Publication
1994-07-29
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Addition of Vice President of Corporate Development

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-11-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: 1992 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-02-05
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation and Rhone-Poulenc Rorer, Inc. Commence Arbitration

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-02-14
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1993 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-02-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 8-K, the Immune Response Corporation]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-02-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Begins Clinical Trial of Multiple Sclerosis Treatment

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-03-25
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces First Quarter 1994 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-04-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: 1994 First Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Granted Australian Patent on Autoimmune Disease Technology

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-05-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Arbitration Confirms the Immune Response Corporation’s Contractual Right to Control Research and Development of HIV Immunotherapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-05-10
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Files Petition to Confirm Recent Arbitration Award

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-06-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation and Rhone-Poulenc Rorer, Inc. Commit $10 Million Additional Funding for HIV Joint Venture

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-07-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Subsidiary, TargeTech, Inc., Licenses Rights for Potential Hepatitis B Treatment to Chugai Pharmaceutical

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994-06-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Immune Response and Rhone-Poulenc Rorer to Expand HIV/AIDS Joint Venture to Include International Territories

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-04-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Invitation to the Immune Response Corporation’s Annual Meeting of Stockholders, 1993]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1993-04-16
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
invitations

[Form 10-K, 1992 Annual Report, the Immune Response Corporation]

Author
Immune Response Corporation
Publication
Immune Response Corporation
1992-12-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

[Letter to Stockholders from Dennis Carlo and Proxy Statement]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1997-04-18
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
letters (correspondence)

The Immune Response Corporation: 1996 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-03-17
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Shalala Hails Finding that IL-2 Boosts Immune Cells; Says Investments in AIDS Research Are Paying Off

Author
Department of Health & Human Services Program Support Center (U.S.)
Publication
Department of Health & Human Services Program Support Center (U.S.)
1996-10-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Makes Public Offering of 2,200,000 Shares of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Publishes Results from Phase I Multiple Sclerosis Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-06-25
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Publishes Additional Findings on T Cells Involved in Psoriasis

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-07-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Licensed Cancer Vaccine Technology Receives United States Patent

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-10-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1997 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-10-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Fourth Quarter and Year-End 1996 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-02-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Results from Phase II Clinical Trials for Rheumatoid Arthritis and Psoriasis

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-01-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Begins Phase II Clinical Trial Using Combination of Antiviral Drugs and Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-02-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Presents Remune Data on Chemokines at Scientific Meeting

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1997-01-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Initiates Collaboration with the University of California, Los Angeles to Develop Brain Cancer Vaccine

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-12-10
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Letter to Jon Cohen from Ronald B. Moss with 2 Press Releases]

Access restricted by copyright holder.
Author
Moss, Ronald B.
Publication
1997-01-28
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
letters (correspondence)

The Immune Response Corporation Reports First Interim Analysis of Phase II Clinical Trial Data Using Remune in Thailand by Trinity Medical Group

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-09-17
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: 1996 Third Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation Announces Exercise of Over-Allotment Option for Public Offering of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-11-05
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 10-Q, the Immune Response Corporation, Quarterly Report for Period Ending September 30, 1996]

Author
Immune Response Corporation
Publication
1996-11-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Announces Publication of Remune Clinical Trial Data

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-09-24
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Clinical Trial in Spain Using Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-10-31
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Third Quarter 1996 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-11-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Combination Drug Trial Using Remune in Collaboration with Glaxo and Merck

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-11-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Postpones Follow-on Public Offering of Common Stock

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-08-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: 1994 Third Quarter Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1994
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press kits

The Immune Response Corporation: First Quarter 1995

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press kits

[Form 10-Q, the Immune Response Corporation, Quarterly Report for Period Ending March 31, 1996]

Author
Immune Response Corporation
Publication
1996-04-30
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports
Back to Top Go to Pagination

The Immune Response Corporation’s Licensed Gene Delivery Technology Receives United States Patent

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-05-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Enters into Collaboration with Bayer Corporation

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-07-09
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation: Annual Report 1995. Crossing the Clinical Stage

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-03-08
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

[Letter to Stockholders from Dennis Carlo with Proxy Statement]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1996-04-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
letters (correspondence)

The Immune Response Corporation’s Licensed B Cell Lymphoma Technology Receives Patents from Europe, Australia and Greece

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-25
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Long-Term Follow-Up Data Published on Initial Patients Treated with Remune

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

Trinity Medical Group Completes $5 Million Equity Investment in the Immune Response Corporation

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-05-01
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation’s Licensed Technology Shown to Eradicate Brain Tumor Cells in Laboratory Animals

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-02
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Addition of Dr. Melvin Perelman to Its Board of Directors

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1996-04-04
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1995 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases
Back to Top Go to Pagination

The Immune Response Corporation Receives FDA Clearance to Begin Psoriasis Phase II Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 10-Q, the Immune Response Corporation, Quarterly Report for the Period Ending June 30, 1995]

Author
Immune Response Corporation
Publication
1995-07-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation Receives FDA Clearance to Begin Phase II Rheumatoid Arthritis Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives FDA Clearance to Begin Psoriasis Phase II Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-19
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

San Diego Regional Cancer Center and the Immune Response Corporation Begin Gene Therapy Clinical Trial for Colon Cancer

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-06-15
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives Approval to Resume Treatment Using the HIV Immunotherapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-06-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Expresses Sorrow at the Death of Its Co-Founder, Dr. Jonas Salk

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-06-23
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Receives FDA Clearance to Begin Phase II Rheumatoid Arthritis Clinical Trial

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-07-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Second Quarter 1995 Financial Results

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1995-07-21
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Letter to Stockholders from Dennis Carlo with Proxy Statement]

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1995-05-12
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
letters (correspondence)
Back to Top Go to Pagination

FDA Advisory Committee Recommends Phase III Clinical Trail of HIV Immunoterapeutic

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-01-26
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Addition of Vice President of Manufacturing

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
1995-05-17
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

The Immune Response Corporation Announces Addition of Vice President of Manufacturing

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-05-17
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
press releases

[Form 10-K, the Immune Response Corporation, Annual Report for Fiscal Year 1994]

Author
Immune Response Corporation
Publication
1995-02-03
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

The Immune Response Corporation: 1994 Annual Report

Access restricted by copyright holder.
Author
Immune Response Corporation
Publication
Immune Response Corporation
1995-04-07
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

[Form 10-Q, the Immune Response Corporation, Quarterly Report for the Period Ending March 31, 1995]

Author
Immune Response Corporation
Publication
1995-05-11
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
reports

Brokers Convention Could Sway Stocks [USA Today ]

Author
Dorfman, Dan
Publication
September 20, 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Biotech Stocks Are Bouncing Back [The Wall Street Journal ]

Author
Torres, Craig
Publication
July 20, 1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Technology Shares Lead Market Higher, But Investors Stay Cautious; Volume Up [The Wall Street Journal ]

Author
Calian, Sara
Publication
September 30, 1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Agouron Deal Underscores Risk of Biotechs' Elite, Too [The San Diego Union-Tribune ]

Author
Kupper, Thomas
Publication
January 28, 1999
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item
Back to Top Go to Pagination

Immune Response Stock Jumps as Study of Vaccine Evaluated [The Wall Street Journal ]

Publication
April 13, 1993
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Partners in Dispute over HIV Team Work [The San Diego Union-Tribune ]

Author
Rose, Craig D.
Publication
February 15, 1994
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Conflict Arises on AIDS Vaccine [The Philadelphia Inquirer ]

Author
Collins, Huntly
Publication
February 15, 1994
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Carlsbad Biotech to Test HIV Drug [The San Diego Union-Tribune ]

Author
Rose, Craig D.
Publication
November 8, 1996
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Cuts Third of Its Jobs [The San Diego Union-Tribune ]

Author
Kupper, Thomas
Publication
June 22, 1999
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Time Running Out for Salk-Backed AIDS Vaccine [The San Diego Union-Tribune ]

Author
Crabtree, Penni
Publication
June 2, 2002
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

HIV Vaccine Buoys Hopes of Investors [The Los Angeles Times ]

Author
Kraul, Chris
Publication
September 24, 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Corp. Relies on Therapeutic Vaccines to Target Diseases [Genetic Engineering News: GEN ]

Author
Sedlak, Bonnie Joy
Publication
October 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Sees Its Future Going Well beyond AIDS Vaccine [Investor's Business Daily ]

Publication
September 11, 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Files to Offer Fewer Shares in Second IPO Try [Investor's Business Daily ]

Author
Daniels, Jeffrey
Publication
April 3, 1990
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item
Back to Top Go to Pagination

Failure of Immune Response Offer May Hamper Other Biotech IPOs [Investor's Business Daily ]

Author
Daniels, Jeffrey
Publication
November 7, 1989
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Hot Stock Not Immune to Drop-Off [USA Today ]

Author
Strauss, Gary
Publication
January 2, 1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Loses Partner [The San Diego Union-Tribune ]

Author
Rose, Craig D.
Publication
March 4, 1995
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Optimism Fades on Immune Response As FDA Meeting Nears [Dow Jones Newswires ]

Author
Mahler, Jonathan
Publication
January 25, 1995
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Street [The Wall Street Journal ]

Author
Power, William
Publication
January 20, 1995
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Immune Response Insiders Sell as Stock Slides [The Wall Street Journal ]

Author
Peers, Alexandra
Publication
May 20, 1992
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Merck Setback Shows Problems of AIDS Drugs [The Wall Street Journal ]

Author
Chase, Marilyn
Publication
November 26, 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item

Battered Biotechs Show Signs of Life [USA Today ]

Publication
November 26, 1991
Series/Folder Title
Marketplace > Companies > Immune Response Corporation > General
Item type:
Newspaper Article

Check your library for this item
Do you have questions about this content? Need to report a problem? Please contact us.